Menlo Therapeutics Inc. (MNLO): Price and Financial Metrics
Menlo Therapeutics Inc. (MNLO)
Today's Latest Price: $1.35 USD
Updated Sep 4 7:42pm
Add MNLO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
MNLO Stock Summary
- With a year-over-year growth in debt of 3,390.94%, Menlo Therapeutics Inc's debt growth rate surpasses 99.06% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Menlo Therapeutics Inc is reporting a growth rate of 255.12%; that's higher than 94.8% of US stocks.
- As for revenue growth, note that MNLO's revenue has grown 667.89% over the past 12 months; that beats the revenue growth of 98.83% of US companies in our set.
- Stocks that are quantitatively similar to MNLO, based on their financial statements, market capitalization, and price volatility, are TRXC, COHR, RENN, FSLR, and CMRX.
- MNLO's SEC filings can be seen here. And to visit Menlo Therapeutics Inc's official web site, go to www.menlotherapeutics.com.
MNLO Stock Price Chart Interactive Chart >
MNLO Price/Volume Stats
| Current price | $1.35 | 52-week high | $7.48 |
| Prev. close | $1.38 | 52-week low | $1.00 |
| Day low | $1.30 | Volume | 1,561,200 |
| Day high | $1.39 | Avg. volume | 2,817,431 |
| 50-day MA | $1.63 | Dividend yield | N/A |
| 200-day MA | $2.95 | Market Cap | 226.38M |
Menlo Therapeutics Inc. (MNLO) Company Bio
Menlo Therapeutics Inc., a biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with prurigo nodularis. It is also developing products that are in Phase II clinical trials in pruritus associated with psoriasis and atopic dermatitis, and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is based in Redwood City, California.
Loading social stream, please wait...